The World Health Organization (WHO), through its Prequalification Unit and Global Tuberculosis Programme, would like to announce future changes to the WHO procedure to determine procurement eligibility for tuberculosis (TB) in vitro diagnostics (IVDs).
The WHO Global TB Programme (GTB) leads and guides the global effort to end the TB epidemic through universal access to people-centered prevention and care, multisectoral action and innovation. As part of its policy development work, WHO GTB has been assessing emerging evidence on TB IVDs and producing recommendations on the use of TB IVDs based on the patient important outcomes, diagnostic accuracy, economic evidence, feasibility, accessibility and equity aspects of specific diagnostic technologies.
Full announcement below for further details...